UVDI Joins APIC to Counter Misinformation and Uplift Science During International Infection Prevention Week

To raise awareness about the importance of infection prevention and the essential role infection preventionists (IPs) play in public health, UVDI, the leading manufacturer of advanced Ultraviolet technology for Hospital Room Disinfection and Indoor Air Quality, is joining the Association for Professionals in Infection Control and Epidemiology (APIC) as a Corporate Sponsor for International Infection Prevention Week (IIPW), October 17–23.

UVDI has introduced several new educational resources for safe, effective UV room disinfection to emphasize the science behind infection prevention, the misinformation that continues to circulate, and how to inspire the next generation of IPs to join the fight. Educational Resources include a series of new Continuing Education webinars including Fact Versus Fiction: Clarifying Myths Regarding UV Room Disinfection, and three whitepapers sharing UV Basics and Beyond. All are accessible on UVDI’s online Learning Hub at www.uvdi.com.

As IPs continue to protect communities from surges in COVID-19 cases and healthcare-associated infections (HAIs), it has never been clearer just how crucial infection prevention and control is to everyone’s health and safety. In recognition of the role that everyone should play in infection prevention, the 2021 IIPW theme is “Make Your Intention Infection Prevention.” APIC has developed downloadable infographics, fact sheets, and social media materials to help educate all audiences on infection prevention and control—the science behind it and its legitimacy as a trusted profession in the healthcare space.

“We honor the dedication and selflessness of Infection Prevention professionals – this week and every week,” said Peter Veloz, CEO, UVDI. “Working with APIC to provide fact-based evidence and resources for safe, effective UV disinfection is a core part of our ongoing commitment to better patient outcomes.”

“We are happy to have UVDI join our other Corporate Sponsors for this year’s International Infection Prevention Week,” said APIC President Ann Marie Pettis, RN, BSN, CIC, FAPIC. “With their help, we are able to reach consumers and other healthcare personnel about how they can make their intention infection prevention.”

UVDI plans to join APIC and other healthcare organizations on Tuesday, October 19 at 12 PM ET for a Twitter chat using #IIPWChat to discuss the impacts of COVID-19, how to counter misinformation with facts, and what it looks like to be an IP. Learn more at www.InfectionPreventionandYou.org/iipw.

SourceUVDI
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version